"Anti angiogenic treatment" trang 1 - tải miễn phí từ tailieunhanh
Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours

Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
6    60    0
Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
10    49    1
Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma - a suitable treatment option: Case report and review of anti-angiogenic treatment options

Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma - a suitable treatment option: Case report and review of anti-angiogenic treatment options
5    42    1
CABOCOL-01 trial: A single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

CABOCOL-01 trial: A single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
12    31    1
Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
13    72    1
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: Hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: Hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
12    73    1
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
10    38    1
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma
9    56    1
Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review

Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
15    90    0